Your browser doesn't support javascript.
loading
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study.
Kähler, Katharina C; Gutzmer, Ralf; Meier, Friedegrund; Zimmer, Lisa; Heppt, Markus; Gesierich, Anja; Thoms, Kai-Martin; Utikal, Jochen; Hassel, Jessica C; Loquai, Carmen; Pföhler, Claudia; Heinzerling, Lucie; Kaatz, Martin; Göppner, Daniela; Pflugfelder, Annette; Bohne, Ann-Sophie; Satzger, Imke; Reinhardt, Lydia; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma.
Afiliação
  • Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.
  • Gutzmer R; Department of Dermatology, University Hospital Hannover, Hannover, Germany.
  • Meier F; Skin Cancer Center, National Center for Tumor Diseases, University Cancer Centre Dresden, Dresden, Germany.
  • Zimmer L; Department of Dermatology, TU Dresden, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Heppt M; Department of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK), Essen, Germany.
  • Gesierich A; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Thoms KM; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
  • Utikal J; Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany.
  • Hassel JC; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Loquai C; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Pföhler C; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Heinzerling L; Department of Dermatology, University Hospital Mainz, Mainz, Germany.
  • Kaatz M; Department of Dermatology, University Hospital Homburg, Homburg, Germany.
  • Göppner D; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Pflugfelder A; Department of Dermatology and Allergology, Ludwig-Maximilian University, München, Germany.
  • Bohne AS; Department of Dermatology, SRH Waldklinikum, Gera, Germany.
  • Satzger I; Department of Dermatology, University Hospital Giessen, Gießen, Germany.
  • Reinhardt L; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Placke JM; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Hannover, Hannover, Germany.
  • Ugurel S; Skin Cancer Center, National Center for Tumor Diseases, University Cancer Centre Dresden, Dresden, Germany.
Front Oncol ; 11: 672172, 2021.
Article em En | MEDLINE | ID: mdl-34109122
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article